# Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24)

Source: https://welltoldgrants.com/grants/rfa-oh-27-048-continuation-and-expansion-of-the-national-mesothelioma/  
Official notice: https://www.grants.gov/search-results-detail/363281

> Centers for Disease Control and Prevention - ERA plans to offer grants of up to $1.1 million (at least $750,000) to any type of organization. It expects to make one award worth $5.5 million in total. It is a forecast: the notice is expected around September 2, 2026, with applications due around November 2, 2026.

| Field | Value |
|---|---|
| Opportunity number | RFA-OH-27-048 |
| Agency | Centers for Disease Control and Prevention - ERA |
| Status | Forecast |
| Deadline | expected November 2, 2026 |
| Award ceiling | $1.1 million |
| Award floor | $750,000 |
| Expected awards | 1 |
| Total funding | $5.5 million |
| Cost sharing | not required |
| Assistance Listings | 93.262 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Applicant institution must have an established registry and tissue bank with the capability of functioning as a national virtual registry and tissue bank for mesothelioma, one in which participating institutions will make available their independent stores of mesothelioma tissue for public access and use through a centralized Internet-based database or registry. This virtual registry and tissue bank must be able to provide a resource for investigators engaged in the research of mesothelioma, to include, but not limited to, biospecimens (blood, plasma, white blood cells, and normal and malignant mesothelioma tissues) together with demographic data such as age, sex, race, occupational history and other epidemiologic information, and clinical data (stage, treatment and survival information).Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement, are not allowed.

## What the grant funds

The National Mesothelioma Virtual Bank (NMVB) was established in 2006 to serve as a resource for malignant mesothelioma research. This funding opportunity will advance biomedical research for malignant mesothelioma by adding more biospecimens together with demographic data and clinical data. Examples of biospecimens include fresh frozen tumor and control tissues, paraffin embedded tissues, blood, DNA, RNA, and protein samples from mesothelioma patients. Demographic data includes age, sex, race, and occupational history. Clinical data includes stage, treatment, and survival information. The virtual registry and tissue bank also serve as a virtual repository and offer a library of biospecimens and data that investigators can use and share, including genomic, transcriptomic, and proteomic data. The NMVB can: Help identify early signs of disease. Support the development of biomarkers that show disease stage and prognosis. Help develop new or improved treatment options. The goal is to continue to expand the NMVB and improve its ability to be a resource for both biomedical researchers and the clinical science community focused on malignant mesothelioma research.

## Questions people ask

### Who can apply for Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24)?

Centers for Disease Control and Prevention - ERA accepts applications from any type of organization. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24)?

Expected deadline November 2, 2026. Confirm the date and time in the official notice on Grants.gov.

### How much funding is available?

Awards of up to $1.1 million each. About $5.5 million in total for one award.